LABANEB INHALATION SOLUTION contains Arformoterol which belongs to the group of medicines called Bronchodilators. It is indicated for the long-term maintenance management of bronchoconstriction (obstruction of airways) in patients with chronic obstructive pulmonary disease (COPD), including emphysema (damage to lung alveoli causing frequent cough) and chronic bronchitis (chronic recurring lung disease with productive cough).
Chronic obstructive pulmonary disease refers to the group of chronic diseases of lung which causes block in the airways. The symptoms include wheezing, difficulty in breathing, cough, etc. Your doctor might ask you to take several diagnostic tests before starting the management with LABANEB INHALATION SOLUTION.
LABANEB INHALATION SOLUTION is not recommended for use in patients having asthma and not using medication for asthma control. LABANEB INHALATION SOLUTION should be used with caution in patients having liver, heart or thyroid problems, high blood pressure, epilepsy (fits) and diabetes.
Caution must be exercised while using LABANEB INHALATION SOLUTION in pregnant and breast-feeding women so, consult with your doctor before taking it. LABANEB INHALATION SOLUTION is generally not recommended for use in children and it should be used with caution in elderly patients (above 65 years of age).
The most common side effects of taking LABANEB INHALATION SOLUTION are chest or back pain, sinus or nasal congestion, diarrhoea, flu-like symptoms such as headache, fever, vomiting, tiredness. Consult your doctor for advice if any of the symptoms worsen or doesn’t improve.
No content available
